Propofol Sedation Guidelines
Introduction to Propofol Sedation
- The American Gastroenterological Association recommends propofol doses of 107-245 mg total for EGD and 144-287 mg total for colonoscopy for endoscopic sedation 1
- An alternative lower-dose approach for endoscopic sedation targets moderate rather than deep sedation, with mean doses of 72 mg for EGD and 94 mg for colonoscopy 1
Special Considerations for Sedation
- The American Society of Clinical Oncology suggests a loading dose of 20 mg and a maintenance infusion of 50-70 mg/h for refractory symptoms at end of life 3
- The European Society of Medical Oncology also recommends a maintenance infusion of 50-70 mg/h for palliative sedation 4
Critical Safety Considerations
- Propofol causes dose-dependent decreases in cardiac output, systemic vascular resistance, and arterial pressure, according to the American Heart Association 1
- The American Society of Anesthesiologists mandates continuous monitoring of heart rate, blood pressure, and oxygen saturation due to the risk of hypotension, which occurs in 5-7% of patients 5
- Propofol has no analgesic properties and must be combined with opioids or other analgesics for painful procedures, as stated by the American Pain Society 2
- The American Society for Parenteral and Enteral Nutrition notes that propofol provides 1.1 kcal/mL from lipid content, which should be accounted for when calculating nutritional requirements in ICU patients 5
Pharmacogenomics and Propofol
- The Clinical Pharmacogenetics Implementation Consortium recommends reducing maintenance infusion to 25 mcg/kg/min (approximately 50% reduction from standard 50-100 mcg/kg/min range) for CYP2B6 poor metabolizers 2
Risks Associated with Propofol
- Doses >70 mcg/kg/min for >48 hours increase risk of Propofol Infusion Syndrome (PRIS), characterized by metabolic acidosis, rhabdomyolysis, arrhythmias, and up to 33% mortality, according to the Society of Critical Care Medicine 2